Psoriasis Vulgaris
📧 Sign up to get email alerts when something new happens for Psoriasis Vulgaris.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2024-04-30Clinical Trial Update: Predicting Inflammatory Skin Disease Response to IL-23 Blockade [Phase 4]
A Phase 4 clinical trial from UC San Francisco evaluated whether biomarkers can predict response to IL-23 blockade in psoriasis vulgaris, wi…
-
CLINICAL_TRIALS trial_result · 2024-02-28Clinical Trial Update: Shuiniujiao Dihuang Decoction With Variation for the Treatment of Psoriasis [Phase 2]
Phase 2 clinical trial exploring Shuiniujiao Dihuang Decoction with variation for treating psoriasis vulgaris has an unknown status.
-
CLINICAL_TRIALS trial_result · 2024-02-05Clinical Trial Update: Therapeutic Drug Monitoring of Risankizumab in Psoriasis Patients (BIOLOPTIM-RIS) [Phase 4]
Phase 4 clinical trial update evaluating therapeutic drug monitoring of risankizumab in psoriasis patients.
-
CLINICAL_TRIALS trial_result · 2024-01-30Clinical Trial Update: Improvement of Psoriasis Patients' Adherence to Topical Drugs [NA]
A completed clinical trial examining adherence improvements to topical therapies in psoriasis vulgaris.
-
CLINICAL_TRIALS trial_result · 2024-01-18Clinical Trial Update: Therapeutic Drug Monitoring of Tildrakizumab in Psoriasis Patients [Phase 4]
Phase 4 clinical trial update evaluating therapeutic drug monitoring of tildrakizumab in psoriasis patients.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2023-11-18Clinical Trial Update: Anti-Inflammatory Effects of 0.045% Tazarotene/0.01% Halobetasol Lotion in Psoriasis [Phase 4]
Phase 4 trial update on anti-inflammatory effects of a tazarotene/halobetasol lotion in psoriasis vulgaris.
-
CLINICAL_TRIALS trial_result · 2023-08-29Clinical Trial Update: Psoriatic Immune Response to Tildrakizumab [Phase 4]
Phase 4 clinical trial update evaluating the psoriatic immune response to tildrakizumab in psoriasis vulgaris.
-
CLINICAL_TRIALS trial_result · 2023-08-25Clinical Trial Update: A Phase 3 Clinical Study of KHK 4827 [Phase 3]
Phase 3 trial update for KHK 4827 across psoriasis-related conditions; study completed.
-
CLINICAL_TRIALS trial_result · 2023-06-18Clinical Trial Update: Using Acetylcysteine and Vitamin E With Psoriasis Vulgaris [Phase 3]
Phase 3 clinical trial evaluating acetylcysteine and vitamin E for psoriasis vulgaris is in progress with unknown status.
-
CLINICAL_TRIALS trial_result · 2023-03-17Clinical Trial Update: Blue Light Phototherapy [NA]
Clinical trial update for blue light phototherapy (completed) with results posted; conditions studied include Grover's Disease and Psoriasis…
-
CLINICAL_TRIALS trial_result · 2023-03-02Clinical Trial Update: A Phase 3 Study of Efficacy and Safety of AK101 in Subjects With Psoriasis [Phase 3]
Phase 3 trial update evaluating efficacy and safety of AK101 in psoriasis vulgaris has completed.
-
CLINICAL_TRIALS trial_result · 2022-08-05Clinical Trial Update: Efficacy and Safety of Novel Formulations of Topical Calcipotriol in Patients With Mild to Moderate Plaque Psoriasis [Phase 1, Phase 2]
Phase 1/2 trial evaluating efficacy and safety of novel topical calcipotriol formulations in mild to moderate psoriasis (psoriasis vulgaris)…
-
CLINICAL_TRIALS trial_result · 2022-02-24Clinical Trial Update: Clinical Trial of Probiotic Supplementation in Psoriasis Vulgaris [Phase 1, Phase 2]
Clinical trial update for probiotic supplementation in psoriasis vulgaris undergoing Phase 1 and Phase 2.
-
CLINICAL_TRIALS trial_result · 2021-11-01Clinical Trial Update: Phase 2, Open-label, Study of KD025 in Subjects With Psoriasis Vulgaris Who Failed First-line Therapy [Phase 2]
Phase 2 open-label study of KD025 in psoriasis vulgaris patients who failed first-line therapy has completed; results posted.
-
CLINICAL_TRIALS trial_result · 2021-09-13Clinical Trial Update: A Safety and Tolerability Study of Belumosudil (KD025) Treatment in Subjects With Moderately Severe Psoriasis Vulgaris [Phase 2]
Phase 2 safety and tolerability study of belumosudil (KD025) in moderately severe psoriasis vulgaris has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2021-09-01Clinical Trial Update: Secukinumab Therapy for the Treatment of Moderate to Severe Plaque Psoriasis With Response Monitoring Using Optical Coherence Tomography (OCT). [Phase 4]
A Phase 4 trial evaluating secukinumab for moderate to severe plaque psoriasis with response monitoring via optical coherence tomography.
-
CLINICAL_TRIALS trial_result · 2021-08-26Clinical Trial Update: Efficacy and Safety of Calcipotriol Plus Hydrocortisone Ointment in Psoriasis Vulgaris on the Face and Skin Folds [Phase 3]
Phase 3 trial evaluating the efficacy and safety of calcipotriol plus hydrocortisone ointment for psoriasis on the face and skin folds; resu…
-
CLINICAL_TRIALS trial_result · 2021-08-06Clinical Trial Update: Pilot Study of Traditional Chinese Medicine (Qing-Re-Liang-Xue Decoction) as Complementary Medicine for Psoriasis Vulgaris of Blood-heat Syndrome. [Phase 2]
Pilot Phase 2 trial investigating Qing-Re-Liang-Xue Decoction as complementary medicine for psoriasis vulgaris.
-
CLINICAL_TRIALS trial_result · 2021-07-27Clinical Trial Update: LEO 80185 Gel (Calcipotriol Hydrate Plus Betamethasone Dipropionate) in Japanese Subjects With Psoriasis [Phase 3]
Phase 3 clinical trial update for LEO 80185 Gel (calcipotriol hydrate plus betamethasone dipropionate) in Japanese subjects with psoriasis v…
-
CLINICAL_TRIALS trial_result · 2021-07-20Clinical Trial Update: A Study Evaluating the Efficacy and Tolerability of Oral Apremilast for the Treatment of Nail Psoriasis [Phase 4]
A Phase 4 trial evaluating oral apremilast for nail psoriasis has completed and posted results on 2021-07-20.
-
CLINICAL_TRIALS trial_result · 2021-06-11Clinical Trial Update: A 12-Day Randomized, Blinded, Vehicle and Active Comparator-Controlled Study to Determine the Efficacy and Safety of Six Concentrations of Topical E6201 Gel in Subjects With Psoriasis Vulgaris [Phase 2]
Phase 2 randomized study evaluating six concentrations of topical E6201 gel for psoriasis vulgaris; completed with posted results.
-
CLINICAL_TRIALS trial_result · 2021-04-09Clinical Trial Update: Efficacy 、Safety and PK of SHR-1314 in Patients With Moderate-to-Severe Plaque Psoriasis [Phase 3]
Phase 3 trial update on SHR-1314 assessing efficacy, safety, and pharmacokinetics in moderate-to-severe plaque psoriasis.
-
CLINICAL_TRIALS trial_result · 2021-02-21Clinical Trial Update: A Maximal Use Trial Evaluating the Pharmacokinetic Profile of MC2-01 Cream in Adolescent Subjects [Phase 2]
Phase 2 pharmacokinetic trial of MC2-01 Cream in adolescents with psoriasis vulgaris has been terminated; results posted.
-
CLINICAL_TRIALS trial_result · 2020-12-16Clinical Trial Update: Efficacy and Safety of LEO 90100 Foam in Japanese Subjects With Psoriasis Vulgaris [Phase 3]
Phase 3 study evaluating the efficacy and safety of LEO 90100 Foam in Japanese subjects with psoriasis vulgaris has completed and results ha…
-
CLINICAL_TRIALS trial_result · 2020-11-27Clinical Trial Update: This Trial is a Randomised, Multicentre, Investigator-blind, Vehicle and Comparator-controlled, Parallel-group Trial With the Purpose of Evaluation Efficacy, Safety and Convenience of the MC2-01 Cream [Phase 3]
Phase 3 trial evaluating MC2-01 Cream for psoriasis vulgaris has completed with posted results.